Niga-ichigoside F1 alleviates DSS-induced ulcerative colitis by inhibiting the NF-κB pathway

被引:0
|
作者
Zhu, Siyi [1 ]
Xu, Peng [1 ]
Chen, Shuai [2 ]
Wang, Zheng [1 ]
机构
[1] Hunan Agr Univ, Coll Biosci & Biotechnol, 1 Nong Da Rd, Changsha 410128, Peoples R China
[2] Wuhan Univ, Sch Publ Hlth, 299 Ba Yi Rd, Wuhan 430071, Peoples R China
关键词
Niga-ichigoside F1; Colitis; NF-kappa B; Network pharmacology; Molecular docking; 23-HYDROXYTORMENTIC ACID; RUBUS-IMPERIALIS; MCP-1; F-1;
D O I
10.1016/j.fbio.2024.104834
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Niga-ichigoside F1, an ursolic acid-type pentacyclic triterpenoid, possesses various pharmacological properties, including anti-tumor, anti-inflammatory, and antinociceptive potentials. However, its function and underlying mechanism in ulcerative colitis (UC) remain unknown. Hence, this study aimed to explore the effect of Nigaichigoside F1 on dextran sulfate sodium (DSS)-induced colitis. The predictive results of network pharmacology identified 311 common targets of Niga-ichigoside F1 and ulcerative colitis. The 4 highest-scoring genes were screened by the BottleNeck method and they were, signal transducer and activator of transcription 3 (STAT3), tumor necrosis factor (TNF), protein kinase B gamma (AKT3), and phosphatidylinositol-4,5bisphosphate 3-kinase, catalytic subunit beta (PIK3CB). KEGG pathway analysis indicated that Niga-ichigoside F1 probably exerted a protective effect on UC through the nuclear factor-kappa B (NF-kappa B) pathways. Molecular docking results showed that Niga-ichigoside F1 had a high affinity for nuclear factor-kappa B-inhibitor of nuclear factor-kappa B (NF-kappa B-I kappa B) complex, with the lowest binding energy. Furthermore, our results in vivo showed that Niga-ichigoside F1 alleviated weight loss, colon shortening, disease activity index (DAI), and histological scoring in DSS-induced colitis mice. Moreover, Niga-ichigoside F1 decreased the levels of inflammatory cytokines tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and interleukin-8 (IL-8) and the expression of oxidative stress markers nitric oxide (NO), myeloperoxidase (MPO), and malonaldehyde (MDA) to mitigate inflammation and intestinal damage. Western blotting results evidenced that Nigaichigoside F1 intervention significantly regulated the NF-kappa B pathway. In conclusion, this study highlighted the potential of Niga-ichigoside F1 in ameliorating colitis, indicating its potential application as a functional food.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Sesamin protects against DSS-induced colitis in mice by inhibiting NF-κB and MAPK signaling pathways
    Chen, Shuang
    Zhang, Chun-Lei
    Shen, Hai-Qing
    Zhou, Xiao-Fei
    Li, Jing-He
    Yu, Jia-Lin
    An, Qiang
    Fu, Ben-Dong
    Yi, Peng-Fei
    FOOD & FUNCTION, 2021, 12 (04) : 1688 - 1694
  • [22] Huangkui Lianchang Decoction Ameliorates DSS-Induced Ulcerative Colitis in Mice by Inhibiting the NF-kappaB Signaling Pathway
    He, Zongqi
    Zhou, Qing
    Wen, Ke
    Wu, Bensheng
    Sun, Xueliang
    Wang, Xiaopeng
    Chen, Yugen
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 2019
  • [23] A Hepatic Oxidative Metabolite of Palmatine Ameliorates DSS-Induced Ulcerative Colitis by Regulating Macrophage Polarization Through AMPK/NF-κB Pathway
    Huang, Qi-Ting
    Ma, Xing-Dong
    Zhang, Jia-Na
    Lin, Wei-Xiong
    Shen, Xue-Xia
    Huang, Zhuo-Wen
    Zhang, Xia
    Wu, Xiao-Yan
    Dou, Yao-Xing
    Su, Zi-Ren
    Su, Ji-Yan
    Li, Yu-Cui
    Liu, Yu-Hong
    Xie, You-Liang
    Lin, Rong-Feng
    Huang, Hai-Yang
    Zhang, Qi-Hui
    Huang, Xiao-Qi
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2025, 53 (01): : 285 - 307
  • [24] Higenamine improves DSS-induced ulcerative colitis in mice through the Galectin-3/TLR4/NF-?B pathway
    Shao, Xiao-xiao
    Xu, Yuan
    Xiao, Hui-ying
    Hu, Yue
    Jiang, Yi
    TISSUE & CELL, 2023, 82
  • [25] Shikonin alleviates DSS-induced ulcerative colitis via inhibiting NLRP3 inflammsome activation
    Run, C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 194 - 194
  • [26] N-Acetyldopamine Dimer Attenuates DSS-Induced Ulcerative Colitis by Suppressing NF-?B and MAPK Pathways
    Huang, Li-Jun
    Wang, Yu-Mei
    Gong, Lei-Qiang
    Hu, Chao
    Gui, Yu
    Zhang, Chen
    Tan, Xue
    Yu, Xian-Kuo
    Liao, Yi-Le
    Luo, Yan
    Tang, Yu-Qin
    Dai, Yi-Fei
    Deng, Yun
    Wang, Dong
    Guo, Da-le
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [27] PRE-TREAT WITH FAECALIBACTERIUM PRAUSNITZII PREVENT THE DSS-INDUCED COLITIS IN MICE BY INHIBITING THE IL23/NF-κB PATHWAY
    Wang, Jingjing
    Cui, Bota
    Zhang, Faming
    Liu, Xingyin
    Ji, Guozhong
    GASTROENTEROLOGY, 2019, 156 (06) : S1160 - S1160
  • [28] Formononetin ameliorates DSS-induced colitis by inhibiting the MAPK/ PPAR-γ/NF-κB/ROS signaling pathways
    Cao, Shen
    Lv, Baojiang
    Tai, Yi
    Zuo, Hong Xiang
    Xing, Yue
    Surh, Young-Joon
    Li, Ming Yue
    Ma, Juan
    Jin, Xuejun
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2025, 496
  • [29] Lacidipine Inhibits NF-κB and Notch Pathways and Mitigates DSS-Induced Colitis
    Yu, Xuezhao
    Li, Cheng
    Tao, Yu
    Xia, Tingting
    Jia, Zhenyu
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (10) : 3753 - 3759
  • [30] Alkaloids from Aconitum carmichaelii Alleviates DSS-Induced Ulcerative Colitis in Mice via MAPK/NF-κB/STAT3 Signaling Inhibition
    Huang, Chuanqi
    Dong, Junli
    Cheng, Lu
    Ma, Haoran
    Wang, Fuqian
    Feng, Yan
    Zhang, Shu
    Li, Yuling
    Zhang, Dan
    Jin, Xiaoqi
    Xiong, Xin
    Jiang, Jie
    Wu, Bin
    Xu, Hongfeng
    Zhang, Geng
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022